A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Clinical trial NCT00140894 · TERMINATED

Trial details

NCT number: NCT00140894
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Adenomatous Polyposis Coli

Start date: 2002-08-06
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.